PD4PD:Partnered Dance for Parkinson Disease (PD4PD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01388556
Recruitment Status : Completed
First Posted : July 6, 2011
Last Update Posted : December 9, 2015
Parkinson's Disease Foundation
Information provided by (Responsible Party):
Gammon M. Earhart, Washington University School of Medicine

Brief Summary:

Exercise is often noted as an important component in a comprehensive approach to the management of Parkinson disease (PD). Most studies of exercise have examined the effects of short-term interventions and have tested participants on their anti-Parkinson medications. As such, these studies have not been able to determine whether or not exercise may have a disease-modifying effect in people with PD. The investigators recent work has shown the potential benefits of dance as a form of exercise for individuals with PD, but, like previous work, has only examined short-term interventions. The investigators think that dance may be ideally suited for study over a longer period of time because dance incorporates many of the features recommended for inclusion in PD-specific exercise programs in a format that is known to be engaging and to enhance motivation to participate in healthful behaviors. As such, the investigators aim to determine both the short- and long-term effectiveness of a community-based dance program for individuals with Parkinson disease and to determine how physical function changes over time in individuals with PD who do not exercise as compared to those who exercise regularly. The investigators hypothesize that:

A) participation in dance will result in improved physical function, cognitive function, mood and quality of life in people with PD within 3 months,

B) additional improvements will be noted at 6 months as compared to 3 months,

C) improvements will be maintained at one year with continued, regular participation in a dance class,

D) those who do not exercise will show significant functional decline over a period of one year, a decline that will not be present in those who dance regularly.

Condition or disease Intervention/treatment Phase
Parkinson Disease Behavioral: Tango dancing Phase 2 Phase 3

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 62 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: PD4PD:Partnered Dance for Parkinson Disease
Study Start Date : July 2009
Actual Primary Completion Date : June 2011
Actual Study Completion Date : June 2011

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Tango
Twice weekly tango dance classes for 12 months.
Behavioral: Tango dancing
Twice weekly tango dance classes

No Intervention: Control Group

Primary Outcome Measures :
  1. Motor Symptom Severity [ Time Frame: 12 months ]
    We will use the Unified Parkinson Disease Rating Scale, Motor Subscale 3, to assess the severity of movement-related symptoms. This is a standanrdized and well-established tool composed of multiple items each scored on a 0-4 scale, with 0 indicating no impairment and 4 indication severe impairment. The overall severity of motor symptoms is determined by summing scores for all of the individual items.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   30 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • normal central and peripheral neurological function
  • at least grade 4/5 strength and normal joint ranges of motion in both legs, - vision corrected to 20/40 or better
  • able to walk independently for 10 feet with or without an assistive device, - normal somatosensory function in the feet (2-point discrimination, vibration, joint kinesthesia, and light touch)
  • no history of vestibular disease

Exclusion Criteria:

  • serious medical problem
  • evidence of abnormality other than PD-related changes on brain imaging (previously done for clinical evaluations-not part of this research)
  • history or evidence of neurological deficit other than PD that could interfere, such as previous stroke or muscle disease
  • history or evidence of orthopedic, muscular, or psychological problem

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01388556

United States, Missouri
Washington University School of Medicine
St. Louis, Missouri, United States, 63108
Sponsors and Collaborators
Washington University School of Medicine
Parkinson's Disease Foundation

Responsible Party: Gammon M. Earhart, Professor, Washington University School of Medicine Identifier: NCT01388556     History of Changes
Other Study ID Numbers: PD4PD-09-0168
PDF ( Other Grant/Funding Number: Parkinson's Disease Foundation )
First Posted: July 6, 2011    Key Record Dates
Last Update Posted: December 9, 2015
Last Verified: December 2015

Keywords provided by Gammon M. Earhart, Washington University School of Medicine:
Parkinson disease
motor symptoms

Additional relevant MeSH terms:
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases